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Abstract
Although the Synthetic Control Method (SCM) is now widely applied, its most commonly-used
inference method, placebo test, is often problematic, especially when the treatment is not uniquely
assigned. This paper discuss the problems with the placebo test under multivariate treatment case.
And, to improve the power of inferences, I further propose an Andrews-type procedure as it potentially
solve some drawbacks of placebo test. Simulations are conducted to show the Andrews’ test is often valid
and powerful, compared with the placebo test.
1 Introduction
When estimating the treatment effect of multiple treatment units using the synthetic control method,
the current literature often considers the placebo test in testing the significance of the average treatment
effect. However, the validity of this test is questionable in this case, mostly because the relatively large
number of the treatment units would lead to imprecise null distribution thus undermine the power of the
test.
Abadie and LHour (2018) discussed the modification of synthetic control estimation method for
multiple treatment case. They choose the weight for control units by considering both the pre-treatment
fit and the discrepancy of controls to reduce the potential bias caused by interpolation. When it comes
to the inference, they apply the permutation test to the ratio of aggregate mean square error between
pre-and post-treatment periods. However, there are two main issues that may disturb the performance
of the test. The heterogeneity in sample units might lead to over-rejecting, and the high probability of
including treated units tends to impair the power of the test.
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Thus, to improve the potential issues with the placebo test, I apply Andrews’ test which is introduced
to assess the instability at the end of a single series in Andrews (2003). The test uses prediction errors
to constitute statistics, which is the average discrepancy between treated group and synthetic control
group in our case. The instability will present if the average treatment effect exists.
Although I only consider the case when there is only one post-treatment period, the inference method
can be further extended to cases with multiple post-treatment periods. The single post-treatment case
is a simplified version of multiple periods thus the issue could be solved by repeatedly implement the
procedures.
This paper is related to a literature that receives increasing attention. Ever since Abadie and Gardeaz-
abal (2003) first introduced the synthetic control method (SCM) and applied it to estimate the treatment
effect of terrorist activities, there are a large number of papers later followed the manner and attempted
to improve the method thus overcoming the limitations of this method. Doudchenko and Imbens (2016)
and Li (2019) applied modified SCM by adding an intercept and abandon the restriction that all weights
sum to one. The method help to find solutions to the case when the controlled units cannot perfectly
form a group that is at the same level of the treated group. Similarly, Ferman and Pinto (2019), in order
to keep the treated group and the control group at a relatively same height, they did the estimation after
demeaning the counterfactual by the actual data. It was showed that the estimator can improve the bias
and variances compare to the traditional estimators. On the other hand, Abadie and LHour (2018) added
a penalty parameter to the original SCM estimator and showed it outperforms estimators using other
estimation methods for the multiply treatment case. For the overview of the SCM, Doudchenko and
Imbens (2016) concluded main modifications and distinguished proper methods for various situations.
Just as Athey and Imbens (2016) acclaimed that SCM is the most important innovation regarding
the policy evaluation method in the past 15 years, the SCM is now widely applied to the evaluation of
treatment in many areas. The point that is inadequately discusses in the wide range of those applications,
however, is the issue with inference. Although Abadie and Gardeazabal (2003), Abadie et al. (2010) and
Abadie et al. (2015) papers introduced the permutation test and kept on improve the test by using
different test statistics and validation method, the amount of literature that question the credibility of
the test and attempted to improve the inference is large.
I mainly focus on the inference of synthetic control methods. Hahn and Shi (2017) simulated several
settings of the permutation test and raised the concern that the placebo test would likely to fail if there are
aggregate shocks present. Although they discussed some potential solutions but not solve the inference
issue indeed. Additionally, regarding the issue of inference of multivariate case, Firpo and Possebom
(2018) tried to modify the inference procedures by assigning different probabilities to the treated unit
using explanatory variables when computing the p-value as well as alter the formation of test statistics.
Cao and Dowd (2019), on the other hand, turned to study the variation between different periods and
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tested the treatment effect and spillover effect using Andrews test which first introduced in Andrews
(2003) paper and further discussed in Andrews and Kim (2006). More papers such as Chernozhukov
et al. (2017) combined the inference of synthetic control method with many other policy intervention
evaluation methods and provided feasible testing methodologies. Based on all those past papers, we
would like to study how the testing approaches perform when the treated unit is not unique. For this
paper, we focus on the inference of the treatment effects. For inference problems regarding the synthetic
control weights, one may refer to the literature on the inference problem with restricted parameter space.
For example, See Andrews (1998), Andrews (2001), and Yu et al. (2019).
The rest of this paper will be arranged as following. Section 2 illustrates the estimation method. In
section 3 I propose the inference method that are used frequently past and the modification of recently
introduced method. Section 4 verifies our advocating of Andrews’ test. Section 5 concludes.
2 Model and estimation
2.1 Setup
With denoting D the dummy of treatment and D = 1 when the unit is treated, we following Rubins
(1974) notation of the potential outcomes of the treated units Yi,t as
Yi,t =

Yi,t(1), if D = 1
Yi,t(0), if D = 0
(1)
Define the potential outcome of non-treated units as Yj,t, the expression of it is the same as for Yi,t.
Suppose that i belongs to the first n1 units out of the total N units and j belongs to the following n0
non-treated units, there is no treatment in first T0 periods thus define it as the pre-treatment period.
For simplicity, assume we only observe 1 post-treatment period. Extension to multiple post-treatment
periods case is straightforward by analysing each period individually following the steps of the single case.
The treated units will show treatment effect αi only during the post-treatment period, By the nature
of treatment, however, we could only observe the actual outcome of treated units under treatment at
the post period but cannot directly observe how it would be like if no treatment. We thus estimate
the treatment effect by the outcome of the synthetic control group following the method introduced in
Abadie and LHour (2018) in later section. In this paper, we consider the case of moderate sample size,
for which the number of units N considered is approximately equal to or smaller than the number of
time periods T .
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2.2 Estimation
There are plenty of synthetic control estimation methods following Abadie and Gardeazabal (2003) paper
which first introduced this estimation method. For example, the modified synthetic control method by
Li (2019) and the demeaned SCM method by Ferman and Pinto (2019). Since we concentrate on the
inference method, the computation method of the synthetic control weights is not essential to our analysis.
Here we apply the method introduced in Abadie and LHour (2018), since it is suited to the case of multiple
treatments.
According to Abadie and LHour (2018), the method of penalized synthetic control gives better es-
timation since it assigns penalty to controls that are distant. Namely,for each i, we solve the following
optimization problem:
min
Wij∈R
T0∑
t=1
(
Yi,t −
N∑
j=n1+1
WijYj,t
)2
+ γ
T0∑
t=1
N∑
j=n1+1
Wij (Yi,t − Yj,t)2 (2)
subject to Wij ≥ 0,
N∑
j=n1+1
Wij = 1,
where Wij are the weights of the jth control to the ith treated unit. Yi and Yj are the vectors of treated
and control units respectively. Solving (2) gives the synthetic control weights, we then sub them in to
the post-treatment period thus calculate the average treatment effect across all treated units. As the
weight would be affected by the penalty parameter γ, the synthetic control estimator is:
ûi,T0+1 =
1
n1
n1∑
i=1
[
Yi,T0+1 −
N∑
j=n1+1
W ∗ij(γ)Yj,T0+1
]
(3)
Here W ∗ij(γ) is the optimal weight after iterations and finding the penalty parameter which minimises
the mean square error. The average estimation error of the pre-treatment period can be computed in
the same way. Additionally, the penalty parameter here is selected by dividing pre-treatment data into
training part and validation part. For each value of γ, we calculate the weights of controls in the training
periods and calculating the mean squared error (MSE) applying the weights to the validation period.
The γ gives minimum MSE will be used then to compute the weights when include all pre-treatment
data.
3 Inference
The core consideration of this paper is to compare the sizes and powers of different tests under various
settings of data. We concern about it due to the speciality of multiple treatment case. Although currently
the most widely applied testing methodology is placebo test as developed in Abadie and Gardeazabal
(2003), the method requires homogeneity of units and is originally developed for single treatment situ-
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ation. For the multiple treated units situation, such as randomly select a group of people or cities to
examines if some specific policies are applicable, it is highly unlikely the treated units will be selected
simply by randomization, thus we are interested in finding out if there are alternative test techniques
that do not require such strong assumptions.
Here in this paper, we consider the test used in Abadie and LHour (2018), which tests the aggregate
effect exhibited by all treated units. While the placebo test check the variation across units, another test
method as practiced in Cao and Dowd (2019) concentrated on the variation of time within the dataset.
In the so called Andrews test, we test if the post-treatment period show different patterns compare to
the pre-treatment periods. We are going to study the pros and cons of both testing methodologies and
suggest which is more suitable for different cases.
3.1 Current methods
Although the mechanism of placebo test is fixed, the statistic used to implement the test is different.
In this paper,we refer from Abadie and LHour (2018), and use the ratio of mean squared prediction
error (RMSPE) to test if the ratio of the post-treatment period is abnormal with respect to the null
distribution. The statistic is expressed as the ratio of the pre- and post-treatement data,
T̂ =
∑T0
t=1
(∑n1
i=1 ûi,t
)2(∑n1
i=1 ûi,T0+1
)2 (4)
Here the ûi,t is the prediction error of each treated period for each treated unit, and it is equal to
Yi,t −∑Nj=n1+1W ∗ij(γ)Yj,t. Theoretically, if the treatment effect exist, the denominator, which represent
the post-treatment aggregate prediction error, will be larger than the case of without treatment, thus
the whole ratio should be smaller. This permutation-type test is then to simply randomly select n1
units out of all treated and untreated units, and the n1 units that selected would then be regarded as the
assuming treated units. For every randomization of treated units, we compute the statistic T (p) after pth
time redefining the treatment group, and aggregating all the T (p) values will form the null distribution
for the statistic under the sharp hypothesis H0 : α1 = α2 = ... = αn1 . Suppose we repeat the step of
randomly select treated units and calculate T (p) for P times, with the calculated test statistic and the
null distribution, the p-value pplacebo is then
1
P + 1
{
1 +
P∑
p=1
1
[
T (p) ≤ T̂
]}
(5)
We reject the null H0 when pplacebo ≤ α with α being the significance level.
The placebo test sets a baseline of the test result, but the result are questionable mainly out of the
concern of two issues. The first question is that if there exist heterogeneity across units, placebo test
tend to over-rejecting the null. While, as discussed in Cao and Dowd (2019), Andrews’ test does not
5
require homogeneity across units but only care about the homogeneity across time.
Another issue concerns about the speciality of multiple treatment case. Since the placebo test establish
its null distribution by repeatedly and randomly select n1 ’treated’ units for many times, under the
multivariate case, the probability that selecting a truly treated units in the repeating rounds is rising
fast, thus the null distribution will move away from the true distribution and therefore reduce the power
of the test. The issue presents since the placebo test makes use of the variation between units while
the limited number of the treated units will make distinguishing abnormal performance easily. When
the treated number increases, it makes recognizing the treated effect harder. We refer to Andrews’ test
to solve this problem since it cares variations between time periods, and treatment effect only presents
in the specific period after treatment thus multiple treated units would not affect the test result. As
Andrews’ test simultaneous solve both issues, we expect it will have better performance. We concentrate
our study in the second issues in this paper, since many past papers have discussed the above question.
3.2 Andrews’ test
In this test, we are going to use the prediction errors ûi,t and ûi,T0+1 as mentioned in previous sections.
By assumption, the prediction error ut is stationary with mean zero, we can thus test if there are
instabilities at the end of the process, i.e., instability at the post-treatment period.
The most straightforward method is to test if the sum of prediction error of the post-treatment period
is at the tail of the null distribution. We could then define the test statistic Ŝ to be
n1∑
i=1
(ûi,T0+1)
2 (6)
It tests if there are treatment effect in one of the post-treatment periods that we interest in. Similarly,
the null in this case is also H0 : α1 = α2 = ... = αn1 and the null distribution constituted by all
S(t) =
∑n1
i=1 (ûi,t)
2 , for each t = 1, 2, ..., T0, using which we could calculate the p-value of this simple
Andrews’ test pandrew which equals
1
T0
T0∑
t=1
1
[
S(t) ≥ Ŝ
]
In other words, pandrew is the average value of the indication function 1
[
S(t) ≥ Ŝ
]
.
Consider the mechanism of the simple Andrews’ test, one important issue is the correlation presents in
the estimation. Usually, we do not hope to apply the estimations to the data that used in the estimation
itself, as the estimated results are surely correlated to the data in this case. Since the correlation might
complicates the inference thus gives an incorrect rejection rate, we improve the Andrews test in part
(i) by using the leave-one-out method for estimation and thus correct the errors as much as possible
(Andrews, 2003). The leave-one-out estimation helps to correct the finite sample bias which improves
the estimation of errors. Then, using the corrected errors, we calculate the p-value of the test.
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For the leave-one-out estimation, we solve the question in (1) using all pre-treatment data ex-
cept for the period t, where t = 1, 2, , T0. With the estimated weights, compute ûi,−t = Yi,−t −∑N
j=n1+1
W−tij (γ)Yj,−t. Here Yi,−t = [Yi,1, Yi,2, , Yi,t−1, Yi,t+1, Yi,T0 ], similar for Yj,−t. Using the cor-
rected error ui,−t, we then compute the test statistics and calculate the p-value pal, which is different
from the one simply using the weights from the estimation section.
Let τ be the significance level and φ = 1 if the hypothesis is rejected and 0 otherwise. The validity
of the test is established as
Theorem 1. Under the sharp null hypothesis that all treatment effects are 0, E[φ]→ τ as N →∞
The usage of this Andrews-type testing procedure is theoretically justified in Cao and Dowd (2019)
and skipped here.
4 Simulation
4.1 Data Generating Process (DGP)
The DGP of the simulation follows the setup of Cao and Dowd (2019) paper. As we consider a factor
model of the expected outcomes yi,t(0) and yj,t(0), for treated units, the expression of the outcomes is:
ym,t(0) = ηt + λ
′
tµm + εm,t (7)
where m representing all i and j. Thus Equation (7) indicates that the expected outcome for all the
units are generated following same manner, but the observed outcome are computed differently. For non-
treated units, yj,T0+1 = yj,T0+1(0)+ej,T0+1 while for the treated units yi,T0+1 = yi,T0+1(0)+αi+ei,T0+1.
When there is no treatment effect, i.e., αi = 0, the observed value of treated units should be similar to
the untreated units.
Along with the baseline model, we further generate the elements needed in the model, that is, for
λt = (λ1,t, λ2,t, λ3,t)
′
ηt = 1 + 0.5δt−1 + ν0,t
λ1,t = 0.5λ1,t−1 + ν1,t
λ2,t = 1 + ν2,t + 0.5ν2,t−1
λ3,t = 0.5λ3,t−1 + ν3,t + 0.5ν3,t−1
The error terms, εm,t and ν are i.i.d. standard normal. The individual effect term µm is drawn from
the U [0, 1] distribution and is fixed for each loop. This is the case where all elements are stationary
thus Andrews test is applicable. For the error process, we first generate it assuming homogeneous errors,
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since homogeneity is necessary for placebo test to be available. It could later be transformed to be
heterogeneous thus to study if the transformed Andrews test will outperform placebo test under both
cases of homogeneity and heterogeneity.
After generating the potential outcomes for all units, the observed outcomes will be accordingly
generated. We set the treatment effect α to be from 0 to 3 and calculate the rejection rate of each test
for different treatment effect cases. Note that the penalty parameter γ to be 0.2 for simplicity, the value
is estimated before the loop and although for different dataset the parameter will change a bit, it is
around 0.2.
4.2 Results
(a) (T0, n1, n0) = (50, 10, 20)
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(b) (T0, n1, n0) = (50, 30, 30)
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Figure 1: Empirical Rejection Rates with different alternatives
8
The graphs of simulation results of two data settings are shown in Figure 1a and 1b.
In general, placebo test is robust in terms of sizes and Andrews’ test (with leave-one-out procedure)
is more powerful. Specifically, the leave-one-out method clearly helped control the size of Andrews test.
The rejection rate of Andrews test with leave-one-out (AN-L) estimation is around 0.05 for all settings
thus it is a valid test.
Figure 1 show the rejection rates of two tests with different settings. In 1a, it is clear to see that
AN-L is correctly sized while has higher power than placebo test. While in 1b as both tests perform
well in size, the AN-L has no obvious difference compare to placebo test. This is due to in setting of
1b, the amount of sample units outnumbers time periods T , as Andrews’ test uses variation in time to
construct the null distribution, in this case the number of T may not enough to recover the true null
distribution. Apart from placebo test and AN-L test, we also included ordinary Andrews’ test. In both
cases it over-reject the null due to the correlations between estimation and data.
5 Conclusion
In this paper, we studied the sizes and powers of two different inference methods and found that in
the case of moderate sample size, if there are more than one treated units, the placebo test might be
less powerful than Andrews’ test (with leave-one-out procedure). The issue presents due to the high
possibility that a treated unit is more likely to be included into the calculation of null distribution thus
makes it shift away from the true distribution. Andrews’ test help to improve the power of the test when
there are sufficient number of pre-treatment time periods. The comparison of the two tests indicate that
both of the tests have their more suitable application cases. Here in this paper, we verified that Andrews’
test is valid and has higher power with multiple treatment case when the number of time periods T is
sufficiently large compare to the number of sample units N .
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